Satsuma Pharmaceuticals Inc (STSA)
NASDAQ:STSA
Holding STSA?
Track your performance easily

Satsuma Pharmaceuticals (STSA) Technical Analysis

0 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
4Neutral
6Bearish
Technical Analysis Consensus
Buy
3Bullish
4Neutral
1Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Satsuma Pharmaceuticals Inc’s (STSA) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Satsuma Pharmaceuticals Inc is a Buy.
Satsuma Pharmaceuticals Inc’s (STSA) 20-Day exponential moving average is 1.10, while Satsuma Pharmaceuticals Inc’s (STSA) share price is $1.1, making it a Buy.
Satsuma Pharmaceuticals Inc’s (STSA) 50-Day exponential moving average is 1.07, while Satsuma Pharmaceuticals Inc’s (STSA) share price is $1.1, making it a Buy.

Satsuma Pharmaceuticals (STSA) Pivot Points

Nov 10, 2024, 03:17 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.90
0.95
1.03
1.08
1.16
1.21
1.29
Fibonacci
0.95
1.00
1.03
1.08
1.13
1.16
1.21
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Satsuma Pharmaceuticals (STSA) Moving Averages

Nov 10, 2024, 03:17 AM
Period
Simple
Exponential
MA5
1.10Sell
1.10Buy
MA10
1.10Sell
1.10Buy
MA20
1.10Buy
1.10Buy
MA50
1.08Buy
1.07Buy
MA100
0.99Buy
1.22Sell
MA200
1.66Sell
2.17Sell
Satsuma Pharmaceuticals Inc’s (STSA) 10-Day exponential moving average is 1.10, while Satsuma Pharmaceuticals Inc’s (STSA) share price is $1.1, making it a Buy.
Satsuma Pharmaceuticals Inc’s (STSA) 100-Day exponential moving average is 1.22, while Satsuma Pharmaceuticals Inc’s (STSA) share price is $1.1, making it a Sell.
Satsuma Pharmaceuticals Inc’s (STSA) stock price is $1.1 and Satsuma Pharmaceuticals Inc’s (STSA) 50-day simple moving average is 1.08, creating a Buy signal.
Satsuma Pharmaceuticals Inc’s (STSA) stock price is $1.1 and Satsuma Pharmaceuticals Inc’s (STSA) 100-day simple moving average is 0.99, creating a Buy signal.
Satsuma Pharmaceuticals Inc’s (STSA) stock price is $1.1 and Satsuma Pharmaceuticals Inc’s (STSA) 200-day simple moving average is 1.66, creating a Sell signal.

Satsuma Pharmaceuticals (STSA) Technical Indicators

Nov 10, 2024, 03:17 AM
Name
Value
Implied Action
RSI (14)
60.79
Neutral
STOCH (9,6)
69.23
Neutral
STOCHRSI (14)
69.23
Neutral
MACD (12,26)
<0.01
Buy
ADX (14)
19.45
Buy
Williams %R
-30.77
Buy
CCI (14)
0.00
-
ATR (14)
0.12
-
Ultimate Oscillator
69.22
Neutral
ROC
0.00
-
Satsuma Pharmaceuticals Inc’s (STSA) Relative Strength Index (RSI) is 60.79, creating a Neutral signal.
Satsuma Pharmaceuticals Inc’s (STSA) Trend Strength Indicator (ADX) is 19.45, creating a Buy signal.

FAQ

Is STSA a Buy, Hold, or Sell?
Based on STSA’s technical indicators, STSA is a Buy.
    What is STSA’s RSI (14)?
    STSA’s RSI (14) is 60.79, which suggests STSA is a Neutral.
      What is STSA’s MACD?
      STSA’s MACD is <0.01, which suggests STSA is a Buy.
        What is STSA’s 5-day moving average?
        STSA’s 5-day moving average is 1.10, which suggests STSA is a Sell.
          What is STSA’s 20-day moving average?
          STSA 20-day moving average is 1.10, which suggests STSA is a Buy.
            What is STSA’s 50-day moving average?
            STSA’s 50-day moving average is 1.08, which suggests STSA is a Buy.
              What is STSA’s 200-day moving average?
              STSA’s 200-day moving average is 1.66, which suggests STSA is a Sell.
                What is STSA’s Williams % R (14)?
                STSA’s Williams % R (14) is -30.77, which suggests STSA is a Buy.
                  What is STSA’s CCI (14)?
                  Currently, no data Available
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis